New drug cocktail targets Hard-to-Treat brain cancers
Disease control
UNKNOWN_STATUS
This early-phase study tests an experimental drug called CTO, alone or combined with standard chemotherapy (Temodar) and radiation, in people with advanced solid tumors or glioblastoma (a type of brain cancer). The main goal is to find the safest dose and check for side effects. …
Phase: PHASE1 • Sponsor: Tactical Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:12 UTC